Published on 14 Nov 2023 on GuruFocus.com via Yahoo Finance
Arcturus Therapeutics Holdings Inc (ARCT) Reports Significant Revenue Growth in Q3 2023
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) announces a substantial increase in revenue for Q3 2023.Extended cash runway to the end of 2026, bolstered by strategic collaborations and milestones.Key clinical programs, including ARCT-154, remain on track with notable progress in pipeline development.
On November 14, 2023, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) released its 8-K filing, detailing its financial results for the third quarter ended September 30, 2023, and providing updates on its pipeline progress. The company reported a significant increase in revenue and extended its expected cash runway, underlining a period of robust financial and operational achievements.
Financial Performance and Revenue Growth